CellforCure is a European contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), with a focus on cell-based and gene-modified therapies. Based in France, the company operates GMP-compliant facilities to support clinical and commercial supply of complex biologics, particularly immune cell therapies such as CAR-T.
Services span process and analytical development, technology transfer, GMP manufacturing of autologous and allogeneic cell therapies, aseptic operations, quality control and quality assurance, batch release support, and cryogenic handling and logistics. CellforCure works with biopharma developers to industrialize ATMP programs in line with European and international regulatory standards, enabling scale-up, multi-site studies, and routine production.